These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

337 related articles for article (PubMed ID: 26209956)

  • 1. A pharmacometric case study regarding the sensitivity of structural model parameter estimation to error in patient reported dosing times.
    Knights J; Rohatagi S
    J Pharmacokinet Pharmacodyn; 2015 Dec; 42(6):627-37. PubMed ID: 26209956
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Estimation of population pharmacokinetic parameters in the presence of non-compliance.
    Mu S; Ludden TM
    J Pharmacokinet Pharmacodyn; 2003 Feb; 30(1):53-81. PubMed ID: 12800807
    [TBL] [Abstract][Full Text] [Related]  

  • 3. On the recording of sample times and parameter estimation from repeated measures pharmacokinetic data.
    Sun H; Ette EI; Ludden TM
    J Pharmacokinet Biopharm; 1996 Dec; 24(6):637-50. PubMed ID: 9300354
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Assessment of dosing impact on intra-individual variability in estimation of parameters for basic indirect response models.
    Krzyzanski W; Dmochowski J; Matsushima N; Jusko WJ
    J Pharmacokinet Pharmacodyn; 2006 Oct; 33(5):635-55. PubMed ID: 16941234
    [TBL] [Abstract][Full Text] [Related]  

  • 5. An estimation method of the clearance for a one-compartment model of a single bolus intravenous injection by a single sampling.
    Funatogawa T; Funatogawa I
    J Biopharm Stat; 2012; 22(1):43-53. PubMed ID: 22204526
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hyperparameter estimation using stochastic approximation with application to population pharmacokinetics.
    Mentré F; Mallet A; Steimer JL
    Biometrics; 1988 Sep; 44(3):673-83. PubMed ID: 3203126
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evaluation of Bayesian estimation of pharmacokinetic parameters.
    Tsuchiwata S; Mihara K; Yafune A; Ogata H
    Ther Drug Monit; 2005 Feb; 27(1):18-24. PubMed ID: 15665741
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparing the performance of FOCE and different expectation-maximization methods in handling complex population physiologically-based pharmacokinetic models.
    Liu X; Wang Y
    J Pharmacokinet Pharmacodyn; 2016 Aug; 43(4):359-70. PubMed ID: 27215925
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Simulation for clinical repeated-dose pharmacokinetic trials applying a peak-and-trough sampling design to estimate oral clearance.
    Ishida K; Kayano Y; Taguchi M; Hashimoto Y
    Biol Pharm Bull; 2007 Nov; 30(11):2159-62. PubMed ID: 17978492
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Simulation studies of errors of parameter estimates in pharmacokinetics.
    Betzien G; Kaufmann B; Schneider B; Ritschel WA
    Arzneimittelforschung; 1985; 35(1):7-14. PubMed ID: 3838673
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Non-compartmental estimation of pharmacokinetic parameters in serial sampling designs.
    Wolfsegger MJ; Jaki T
    J Pharmacokinet Pharmacodyn; 2009 Oct; 36(5):479-94. PubMed ID: 19847629
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Stochastic differential equations in NONMEM: implementation, application, and comparison with ordinary differential equations.
    Tornøe CW; Overgaard RV; Agersø H; Nielsen HA; Madsen H; Jonsson EN
    Pharm Res; 2005 Aug; 22(8):1247-58. PubMed ID: 16078134
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Some considerations on the design of population pharmacokinetic studies.
    Duffull S; Waterhouse T; Eccleston J
    J Pharmacokinet Pharmacodyn; 2005 Aug; 32(3-4):441-57. PubMed ID: 16284917
    [TBL] [Abstract][Full Text] [Related]  

  • 14. An estimation method of the half-life for a one-compartment model of a single bolus intravenous injection by a single sampling.
    Funatogawa T; Funatogawa I; Yafune A
    J Biopharm Stat; 2007; 17(5):827-37. PubMed ID: 17885868
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Estimation of pharmacokinetic parameters by orthogonal regression: comparison of four algorithms.
    Tod M; Aouimer A; Petitjean O
    Comput Methods Programs Biomed; 2002 Jan; 67(1):13-26. PubMed ID: 11750944
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Contribution of Trough Concentration Data in the Evaluation of Multiple-Dose Pharmacokinetics for Drugs with Delayed Distributional Equilibrium and Long Half-Life.
    Choi S; Jeon S; Yim DS; Han S
    Drug Des Devel Ther; 2020; 14():811-821. PubMed ID: 32158198
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparison of ED, EID, and API criteria for the robust optimization of sampling times in pharmacokinetics.
    Tod M; Rocchisani JM
    J Pharmacokinet Biopharm; 1997 Aug; 25(4):515-37. PubMed ID: 9561492
    [TBL] [Abstract][Full Text] [Related]  

  • 18. TK Modeler version 1.0, a Microsoft® Excel®-based modeling software for the prediction of diurnal blood/plasma concentration for toxicokinetic use.
    McCoy AT; Bartels MJ; Rick DL; Saghir SA
    Regul Toxicol Pharmacol; 2012 Jul; 63(2):333-43. PubMed ID: 22504463
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Efficient pharmacokinetic modeling of complex clinical dosing regimens: the universal elementary dosing regimen and computer algorithm EDFAST.
    Sebaldt RJ; Kreeft JH
    J Pharm Sci; 1987 Feb; 76(2):93-100. PubMed ID: 3572761
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A point estimator for the time course of drug release.
    Koehne-Voss S; Pigeot I
    Biom J; 2009 Feb; 51(1):146-58. PubMed ID: 19219906
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.